Literature DB >> 20412395

Regionally distinct white matter lesions do not contribute to regional gray matter atrophy in patients with multiple sclerosis.

Ronald Antulov1, Dominic A Carone, Jared Bruce, Viritha Yella, Michael G Dwyer, Christopher W Tjoa, Ralph H B Benedict, Robert Zivadinov.   

Abstract

PURPOSE: To determine to what extent T1- and T2-regional lesion volumes (RLVs) contribute to total and/or regional gray matter (GM) atrophy in multiple sclerosis (MS).
METHODS: We studied 110 (67 relapsing-remitting and 43 secondary-progressive) MS patients. SABRE program was used to parcel the brain into 13 regions per hemisphere. Total and regional GM fractions (GMFs) were determined in each region to correct for intraregional size variability. Partial correlations were used to determine associations (holding the converse constant) between RLVs, GMF, and regional GMFs (P < .001 to avoid Type 1 error).
RESULTS: Partial correlations between RLVs and regional GMFs (controlling for total GMF) for the total MS group were not significant for any of the 26 regions for T2, whereas they were significant for two of the 26 regions for T1. Partial correlations between RLVs and total GMF (controlling for regional GMF) for the total MS group were significant in 9 of 26 regions for T2 (largest r = right lateral inferior frontal, -.45) and 5 of 26 regions for T1 (largest r = right inferior parietal, -.45).
CONCLUSIONS: Results suggest a model whereby a distinct generalized disease process accounts for GM atrophy better than regionally distinct Wallerian degeneration.
© 2010 by the American Society of Neuroimaging.

Entities:  

Mesh:

Year:  2010        PMID: 20412395     DOI: 10.1111/j.1552-6569.2010.00482.x

Source DB:  PubMed          Journal:  J Neuroimaging        ISSN: 1051-2284            Impact factor:   2.486


  5 in total

1.  Subcortical and cortical gray matter atrophy in a large sample of patients with clinically isolated syndrome and early relapsing-remitting multiple sclerosis.

Authors:  N Bergsland; D Horakova; M G Dwyer; O Dolezal; Z K Seidl; M Vaneckova; J Krasensky; E Havrdova; R Zivadinov
Journal:  AJNR Am J Neuroradiol       Date:  2012-04-12       Impact factor: 3.825

2.  Multimodal quantitative magnetic resonance imaging of thalamic development and aging across the human lifespan: implications to neurodegeneration in multiple sclerosis.

Authors:  Khader M Hasan; Indika S Walimuni; Humaira Abid; Richard E Frye; Linda Ewing-Cobbs; Jerry S Wolinsky; Ponnada A Narayana
Journal:  J Neurosci       Date:  2011-11-16       Impact factor: 6.167

3.  Advances in understanding gray matter pathology in multiple sclerosis: are we ready to redefine disease pathogenesis?

Authors:  Robert Zivadinov; Istvan Pirko
Journal:  BMC Neurol       Date:  2012-03-06       Impact factor: 2.474

4.  Quantification of multiple-sclerosis-related brain atrophy in two heterogeneous MRI datasets using mixed-effects modeling.

Authors:  Blake C Jones; Govind Nair; Colin D Shea; Ciprian M Crainiceanu; Irene C M Cortese; Daniel S Reich
Journal:  Neuroimage Clin       Date:  2013-08-13       Impact factor: 4.881

5.  Segmented corpus callosum diffusivity correlates with the Expanded Disability Status Scale score in the early stages of relapsing-remitting multiple sclerosis.

Authors:  Carolina de Medeiros Rimkus; Thiago de Faria Junqueira; Dagoberto Callegaro; Maria Concepción García Otaduy; Claudia da Costa Leite
Journal:  Clinics (Sao Paulo)       Date:  2013       Impact factor: 2.365

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.